[1] Craighead JE, Abraham JL, Churg A et al : The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Arch Pathol Lab Med 106: 544-597, 1982.
[2] Damhuis RAM, Planteydt HT: Trends in incidence of pleural mesothelioma in the Rotterdam area. Int.J.Cancer 60: 883, 1995.
[3] Aberle DR, Barnes JR: Computerized tomography of asbestos-related pulmonary parenchymal and pleural disease. Clin Chest Med 12: 115-131, 1991.
[4] Leff A, Hopewell PC, Costello J: Pleural effusion from malignancy. Ann Intern Med 88: 532-537, 1978.
[5] Rusch VW: A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest 108:1122–1128, 1995.
[6] Patz EF, Rusch VW, Heelan R: The proposed new international TNM staging system for malignant pleural mesothelioma: application to Imaging. AJR 166: 323-327, 1996.
[7] Marom EM, Erasmus JJ, Pass HI et al The role of imaging in malignant pleural mesothelioma. Semin Oncol 29: 26–35, 2002.
[8] Miller BH, Rosado-de-Christenson ML, Mason AC, Fleming MV, White CC, Krasna MJ: Malignant Pleural Mesothelioma: Radiologic-Pathologic Correlation. RadioGraphics 16: 613-644, 1996.
[44] Patz EF, Shaffer K, Piwnica-Worms DR, Jochelson M, Sarin M, Sugarbaker DJ, Pugatch RD: Malignant pleural mesothelioma: value of CT and RM imaging in predicting resecability. AJR 159: 961-966, 1992.
[56] Rusch VW, Piantadosi S, Holmes EC. The role of extrapleural pneumonectomy in malignant pleural mesothelioma: a Lung Cancer Study Group trial. J Thorac Cardiovasc Surg. 102:1-9, 1991.
[68] Chang MY, Sugarbaker DJ. Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma: techniques and complications. Thorac Surg Clin 14: 435-45, 2004.
[69] Sugarbaker DJ, Jaklitsch MT, Bueno R, et al. Prevention, early detection and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 128:138-46, 2004.
[70] Sugarbaker DJ, Garcia JP, Richards WG, et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma: results in 120 consecutive patients. Ann Surg 224:288-94, 1996.
[74] Bonomo Lorenzo, Beatrice Feragalli, Rocco Sacco, Biagio Merlino, Mari Luigia Storto: Malignant pleural disease European Journal of Radiology 34: 98-118, 2000.
[79] Leung AN, Müller NL, Miller RR: CT in differential diagnosis of diffuse pleural disease. AJR 154: 487-492, 1990.
[82] Benamore R.E. et al. Use of imaging in the managemrnt of malignant pleural mesotelioma. Clinical Radilogy 60, 1237-1247, 2005.
[97] Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, DeCamp MM, Swanson SJ, Bueno R, Lukanich JM, Baldini EH, Mentzer SJ: Resection margins, extrapleural nodal status and cell type determine postoperative long-term survival in
trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117: 54-65, 1999.
[102] International Mesothelioma Interest Group: A proposed new international TNM staging system for malignant pleural mesothelioma. Chest 108: 1122-1128, 1995.
[104] Rusch VW, Godwin JD, Shuman WP: The role of computed tomography scanning in the initial assessment and the follow-up of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 96: 171-177, 1988.
[105] Heelan RT, Rusch VW, Begg CB, Panicek DM, Caravelli JF, Eisen C: Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. AJR 172: 1039-1047, 1999.